[Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis]
- PMID: 19953218
- DOI: 10.1007/s00105-009-1841-y
[Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis]
Abstract
Background: The purpose of this study was to evaluate the efficacy and tolerability of aluminium chloride gel for treatment of axillary hyperhidrosis.
Patients and methods: A total of 20 patients aged 22-38 (mean age: 26.9+/-4.3) with idiopathic axillary hyperhidrosis were included and treated with an antiperspirant (Sweat-off, Sweat-off GmbH, Hügelsheim). Study duration was 42 days. Treatment efficacy was evaluated clinically, as well as by starch-iodine test, gravimetric analysis and evaluation of the skin surface pH.
Results: After treatment there was a significant clinical improvement accompanied by significant qualitative and quantitative reduction of sweat as well as a significant reduction of skin surface pH. Except for slight skin irritation in 6 patients, there were no other side effects. Patient satisfaction improved markedly during the study.
Conclusion: Treatment of axillary hyperhidrosis with aluminium chloride is an effective, safe and inexpensive treatment modality.
Similar articles
-
Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride.J Dtsch Dermatol Ges. 2012 Feb;10(2):115-9. doi: 10.1111/j.1610-0387.2011.07750.x. Epub 2011 Aug 16. J Dtsch Dermatol Ges. 2012. PMID: 21848980 Clinical Trial.
-
Comparison of a novel aluminum lactate-based with an aluminum chloride-based antiperspirant in excessive axillary and inguinal perspiration: first randomized controlled trial.J Dtsch Dermatol Ges. 2022 Dec;20(12):1589-1601. doi: 10.1111/ddg.14898. Epub 2022 Dec 10. J Dtsch Dermatol Ges. 2022. PMID: 36495093 Clinical Trial.
-
An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis.J Drugs Dermatol. 2009 May;8(5):477-80. J Drugs Dermatol. 2009. PMID: 19537371 Clinical Trial.
-
Topical pharmacological treatment.Curr Probl Dermatol. 2002;30:30-43. doi: 10.1159/000060693. Curr Probl Dermatol. 2002. PMID: 12471696 Review. No abstract available.
-
Topical therapies in hyperhidrosis care.Dermatol Clin. 2014 Oct;32(4):485-90. doi: 10.1016/j.det.2014.06.008. Epub 2014 Jul 29. Dermatol Clin. 2014. PMID: 25152341 Review.
Cited by
-
Treatment of Hyperhidrosis: An Update.Am J Clin Dermatol. 2022 Sep;23(5):635-646. doi: 10.1007/s40257-022-00707-x. Epub 2022 Jul 1. Am J Clin Dermatol. 2022. PMID: 35773437 Review.
-
[Antiperspirants for the therapy of focal hyperhidrosis].Hautarzt. 2012 Jun;63(6):452-5. doi: 10.1007/s00105-012-2330-2. Hautarzt. 2012. PMID: 22653180 German.
-
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.Crit Rev Toxicol. 2014 Oct;44 Suppl 4(Suppl 4):1-80. doi: 10.3109/10408444.2014.934439. Crit Rev Toxicol. 2014. PMID: 25233067 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources